The case of a 20 year old woman is reported with Budd-Chiari 
Hepatic venous outflow block or Budd-Chiari syndrome is a severe liver disease with a three year survival rate of 500/o.l Several conditions have been implicated as a cause of BuddChiari syndrome, including myeloproliferative disorders,2 paroxysmal nocturnal haemoglobinuria,3 the presence of lupus anticoagulant,4-6 oral contraceptives,7 pregnancy, 8 and others.9 10 In a small number of cases Budd-Chiari syndrome is associated with the presence of lupus anticoagulant.4-6 Anticardiolipin antibodies are similar to lupus anticoagulant antiphospholipid antibodies, which have been described in patients with recurrent arterial and venous thrombosis, thrombocytopenia, fetal loss or miscarriage. This syndrome has been called the antiphospholipid antibody syndrome. 1 were visualised. The right hepatic vein was obliterated ( Figure) .
Further investigation of the cause of the Budd-Chiari syndrome was performed. Antibodies against extractable nuclear antigen, antinuclear antibodies, rheumatoid factor, and Treponema palladium haemaglutination antibodies could not be detected. The direct and indirect Coombs' test and Ham's test were negative. Antithrombin III, protein S and C concentrations were normal. The prothrombin time was normal, while aPTT was slightly raised. Lupus anticoagulant and anticardiolipin antibodies were found. Culture of bone marrow with and without erythropoietin showed a normal growth pattern. We concluded that this patient had a Budd-Chiari syndrome because of lupus anticoagulant and anticardiolipin antibodies. Ascites was successfully treated with paracentesis and diuretics. Coumarin treatment was started. After six months, the diuretics were stopped without recurrence of ascites. After one year we decided to stop the oral anticoagulants.
Within a month she redeveloped ascites. After the oral anticoagulation treatment and diuretics were started again, she remained well for another five years. Repeat magnetic imaging showed no progression of the BuddChiari syndrome. She then wanted to have a baby despite having been informed of the risk of deterioration of the Budd-Chiari syndrome and obstetrical complications.
After several months, she returned because of an amenorrhoea of four weeks' duration. The oral anticoagulants were stopped; heparin 7 500 IE twice daily subcutaneously was started. Fourteen days later she had the same complaints as at the first admission five years previously. On physical examination no abnormalities were found. Laboratory investigation showed several abnormalities. Haemoglobin, [6] [7] In our patient two possible causes for the hepatic vein thrombosis were found, namely the use of oral contraceptives and the presence of lupus anticoagulant and anticardiolipin antibodies. Longterm use of oral contraceptives increases the risk of venous thrombosis by exacerbating an underlying thrombogenic condition such as paroxysmal nocturnal haemoglobinuria or a myeloproliferative disease. 2 7 15 As mentioned such abnormalities were not found in this patient. The most likely cause in our patient is therefore the lupus anticoagulant and anticardiolipin antibodies. Lupus anticoagulant and anticardiolipin antibodies are both antiphospholipid antibodies. 1 16 17 Antiphospholipid antibodies are associated with venous and arterial thrombosis and recurrent miscarriage. " 1 17 Lupus anticoagulant is an immunoglobulin of IgG or IgM class with a tendency to adhere to the phospholipid portion of the prothrombin activator complex resulting in prolongation of the aPTT. At presentation and during pregnancy our patient had a prolonged aPTT', with detectable lupus anticoagulant and anticardiolipin antibodies.
Anticardiolipin The treatment of choice in patients with Budd-Chiari and the presence of lupus anticoagulant and anticardiolipin antibodies is coumarin anticoagulation.4 6 22 Our patient was successfully treated by coumarin anticoagulation; ascites was treated by paracentesis and diuretics. It was possible to stop the diuretics after six months of treatment.
The longterm prognosis of patients with the Budd-Chiari syndrome resulting from lupus anticoagulants is not well known. Several reports with long survival after the diagnosis have been described; however, rapid deterioration and death have also been reported.46
Pregnancy is a risk factor for the development of Budd-Chiari syndrome; but, on the other hand, several cases of successful pregnancy in patients with the Budd-Chiari syndrome have been reported. 26 The presence of lupus anticoagulant and the high concentrations of anticardiolipin are associated with venous and arterial thrombosis, increased fetal loss or recurrent miscarriage." 1720 Despite being warned about the risks our patient became pregnant and despite subcutaneous heparin the patient had a miscarriage at six weeks of pregnancy and developed ascites and severe thrombocytopenia.
High concentrations of IgG anticardiolipin antibodies are closely correlated by recurrent fetal loss, thrombocytopenia, and thrombosis and have a high predictive value of renewed problems in subsequent pregnancies."1 23 Our patient has high IgG anticardiolipin antibodies, suggesting again problems in another pregnancy. To prevent complications in patients with lupus anticoagulant and high concentrations of anticardiolipin antibodies some have advocated aspirin, heparin, and corticosteroids. 20 23 24 27 28 The role of corticosteroids in the treatment of this condition is not clearly defined.20 22 24 28 The good clinical response to oral anticoagulants in our patient illustrates the importance of testing patients with Budd-Chiari syndrome for anticardiolipin antibodies and lupus anticoagulant, and, if positive, of giving prolonged oral anticoagulation.
